Radioembolization of liver tumors with yttrium-90 microspheres.
about
Transarterial radioembolization using yttrium-90 microspheres in the treatment of hepatocellular carcinoma: a review on clinical utility and developmentsYttrium-90 radioembolization of liver tumors: what do the images tell us?Radioembolization with Yttrium-90 microspheres in hepatocellular carcinoma: Role and perspectivesNeuroendocrine pancreatic tumors: guidelines for management and updateMolecular diagnosis of intrahepatic cholangiocarcinoma.Evaluation of the delivered activity of yttrium-90 resin microspheres using sterile water and 5 % glucose during administration.68Ga and 188Re Starch-Based Microparticles as Theranostic Tool for the Hepatocellular Carcinoma: Radiolabeling and Preliminary In Vivo Rat StudiesKi67 score as a potential predictor in the selection of liver-directed therapies for metastatic neuroendocrine tumors: a single institutional experienceTc-99m macro aggregated albumin scintigraphy - indications other than pulmonary embolism: A pictorial essayTreating hepatocellular carcinoma with 90Y-bearing microspheres: a reviewCholangiocarcinoma--controversies and challenges.Liver resection combined with local ablation: where are the limits?Arterial therapies of non-colorectal cancer metastases to the liver (from chemoembolization to radioembolization).Clinical implications of the body surface area method versus partition model dosimetry for yttrium-90 radioembolization using resin microspheres: a technical review.Neuroendocrine neoplasms of the gut and pancreas: new insights.Treatment options for unresectable neuroendocrine liver metastases.Technical Considerations of Phosphorous-32 Bremsstrahlung SPECT Imaging after Radioembolization of Hepatic Tumors: A Clinical Assessment with a Review of Imaging Parameters.Hepatic radioembolization as a bridge to liver surgery.Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres.Radioembolization of hepatocarcinoma with (90)Y glass microspheres: development of an individualized treatment planning strategy based on dosimetry and radiobiology.A descriptive analysis of remnant activity during (90)Y resin microspheres radioembolization of hepatic tumors: technical factors and dosimetric implications.The Post-SIR-Spheres Surgery Study (P4S): Retrospective Analysis of Safety Following Hepatic Resection or Transplantation in Patients Previously Treated with Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres.Interventional radiology and the care of the oncology patient.Evaluation and management of pancreatic lesions in patients with von Hippel-Lindau disease.Diffusion-weighted magnetic resonance imaging predicts survival in patients with liver-predominant metastatic colorectal cancer shortly after selective internal radiation therapy.Impact of SPECT corrections on 3D-dosimetry for liver transarterial radioembolization using the patient relative calibration methodology.Patient dosimetry in nuclear medicine.Intrahepatic cholangiocarcinoma in a transplant liver--selective internal radiation therapy followed by right hemihepatectomy: report of a case.Theranostics in nuclear medicine practiceYttrium-90 microsphere radioembolization for treatment of lung cancer hepatic metastases.Hepatic volume changes induced by radioembolization with 90Y resin microspheres. A single-centre study.3D modeling of effects of increased oxygenation and activity concentration in tumors treated with radionuclides and antiangiogenic drugs.Immunogenic cell death biomarkers HMGB1, RAGE, and DNAse indicate response to radioembolization therapy and prognosis in colorectal cancer patients.Evaluation of a semiautomated lung mass calculation technique for internal dosimetry applications.Safety of selective internal radiation therapy (SIRT) with yttrium-90 microspheres combined with systemic anticancer agents: expert consensus.Improving quality of life in patients with pancreatic neuroendocrine tumor following peptide receptor radionuclide therapy assessed by EORTC QLQ-C30.Computational particle-haemodynamics analysis of liver radioembolization pretreatment as an actual treatment surrogate.Prognostic factors for prediction of survival of hepatocellular cancer patients after selective internal radiation therapy.Robust evidence for long-term survival with 90Y radioembolization in chemorefractory liver-predominant metastatic colorectal cancer.Prognostic value of pretreatment diffusion-weighted magnetic resonance imaging for outcome prediction of colorectal cancer liver metastases undergoing 90Y-microsphere radioembolization.
P2860
Q26852174-7019B0EC-48BC-4214-A899-1528C25A635BQ26997064-C08850AD-FCAD-457A-9E96-F57E3BB50128Q27023616-82CD6CFF-7680-419C-8D61-90926D798885Q28256132-2FCD96A1-BAC9-477D-96EC-84E5F4D7B28FQ35592221-565F12CA-86F1-4F76-B5A7-307E22A0D1A2Q36157591-B2170C6B-BFC6-47EE-926B-8D25EF2FB5CCQ36163785-3294A483-FC0C-4BDF-971F-8F3A7F1524B6Q36936986-6BADA90B-26F3-452A-B0FB-AEE5DDD87157Q37293626-EDF4C91D-027B-4AE2-9E10-CE9DC709E83DQ37474833-515749F8-BB0E-4961-9F05-8579F724B527Q37860916-32426B9D-0595-4BDF-A3F3-789405ADE9C4Q37871748-02E8F338-52FE-4A09-B924-985FE35873F5Q37876332-16C9A591-C56A-4D0C-8728-C9898F71D386Q37885238-4E7ED46C-7B65-42E9-B7EB-F6FFA0C19BF9Q37909911-A941FBB1-B57C-4F13-9C23-46A5B2498D93Q38014498-E9A74F2B-4710-473B-822A-61ABA570AD3EQ38209672-E3C6736C-57E5-4208-82F4-357D692B4D61Q38240151-5FD037CD-D450-449B-8AF8-67246199B2AEQ38534001-6F94B7B4-DB96-4B26-BCF5-B20B4E999510Q38538075-C2EBC301-7962-4D98-A56B-E915C102F7D9Q38675831-B7144A2E-D8F1-4723-B87E-14397A6B580EQ38707783-A50BD761-0E55-468B-BA41-7708CB305B87Q38757170-90728F01-0094-4F47-9D0C-540345A802F6Q38794106-204240C7-3CFC-4A35-9F35-A74EBB933038Q38856938-C0F88141-4BC3-4102-B196-006934CF2B46Q39637887-1B419B57-D03E-443F-9A5E-F619DD4026A6Q41142775-CC4F1030-9FA4-413E-B863-45FFD72B051DQ42015945-6AF3CE51-8022-4593-9621-563B41AB3122Q42373162-0A7D68BE-9C0B-4A9F-886A-A1E95AAD77DEQ42702659-614F7070-FAD2-4AE3-ACB2-A8A44DA47685Q43738534-0276833E-892A-4334-ABD0-AD2F882A57FEQ45785165-7D99B032-CF70-40B8-94A9-2E91A514482DQ46430969-2B613494-7781-4178-8F98-FAF129954CF3Q46931125-8CBCB556-C6B7-433E-B74C-E8FB47BFFBD3Q47134709-631401B2-2EE6-4DD7-92F0-168B5EB12D5DQ47653267-20CA7707-ACFA-40A3-9196-8C15B632108BQ50246186-41B20BAA-9851-41C9-B94C-DC3FE62A012DQ51043205-7266D624-542D-49AF-A03C-6DC4EF102B1AQ51382187-EF82A6DA-7319-4B15-A344-40BF26D80948Q52889145-3FBD2BD0-B57E-4167-A02A-BC66A02B2A55
P2860
Radioembolization of liver tumors with yttrium-90 microspheres.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Radioembolization of liver tumors with yttrium-90 microspheres.
@en
Radioembolization of liver tumors with yttrium-90 microspheres.
@nl
type
label
Radioembolization of liver tumors with yttrium-90 microspheres.
@en
Radioembolization of liver tumors with yttrium-90 microspheres.
@nl
prefLabel
Radioembolization of liver tumors with yttrium-90 microspheres.
@en
Radioembolization of liver tumors with yttrium-90 microspheres.
@nl
P2093
P1476
Radioembolization of liver tumors with yttrium-90 microspheres.
@en
P2093
Hans-Jürgen Biersack
Hojjat Ahmadzadehfar
Samer Ezziddin
P304
P356
10.1053/J.SEMNUCLMED.2009.11.001
P577
2010-03-01T00:00:00Z